A hemodialysis patient with acquired factor V inhibitor who developed cerebral hemorrhage: A case report

[1]  K. Kohagura,et al.  Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease , 2022, CEN Case Reports.

[2]  Y. Ogawa,et al.  Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: A single-center analysis. , 2022, Thrombosis research.

[3]  A. Ichinose,et al.  A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan , 2021, Seminars in Thrombosis and Hemostasis.

[4]  K. Ohmura,et al.  Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan , 2021, International Journal of Hematology.

[5]  V. Calafiore,et al.  A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents , 2020, Clinical case reports.

[6]  Harpreet S Gill,et al.  Acquired Factor V Inhibitor After Antibiotic Therapy: A Clinical Case Report and Review of the Literature , 2020, Cureus.

[7]  E. Gouider,et al.  Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis. , 2020, Annales de Biologie Clinique.

[8]  Teruhito Takakuwa,et al.  Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment , 2019, Acta Haematologica.

[9]  Hui Peng,et al.  Severe serous cavity bleeding caused by acquired factor V deficiency associated with lymphatic leakage in a hemodialysis patient: A case report , 2019, World journal of clinical cases.

[10]  K. Morikane,et al.  A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis , 2018, International Journal of Hematology.

[11]  H. Narahara,et al.  High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors , 2017, Internal medicine.

[12]  R. Koda,et al.  Acquired Factor V Inhibitors in a Patient with End-stage Renal Disease , 2016, Internal medicine.

[13]  M. Oya,et al.  Renal hemorrhage caused by acquired inhibitors to coagulation factors VIII and V in a hemodialysis patient , 2016, CEN Case Reports.

[14]  Kenji Tsuji,et al.  Membranous nephropathy with acquired factor V inhibitor: a case report , 2013, BMC Research Notes.

[15]  G. Lippi,et al.  Acquired factor V inhibitors: a systematic review , 2011, Journal of Thrombosis and Thrombolysis.

[16]  S. McRae,et al.  Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  M. Ishizu,et al.  Severe hemorrhagic tendency due to factor V inhibitor in a hemodialysis patient: a case report , 2003 .

[18]  Y. Aizawa,et al.  Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.